Fakih M - Search Results

1

RAS and BRAF in metastatic colorectal cancer management.

Gong J, Cho M, Fakih M. Gong J, et al. Among authors: fakih m. J Gastrointest Oncol. 2016 Oct;7(5):687-704. doi: 10.21037/jgo.2016.06.12. J Gastrointest Oncol. 2016. PMID: 27747083 Free PMC article. Review.

2

5-fluorouracil, leucovorin and oxaliplatin plus bevacizumab in the first-line treatment of metastatic colorectal cancer: a single-institute study.

Bir A, Tan W, Wilding GE, Lombardo J, Fakih MG. Bir A, et al. Oncology. 2007;72(1-2):4-9. doi: 10.1159/000110546. Epub 2007 Oct 30. Oncology. 2007. PMID: 17971679

3

KRAS status and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFOX chemotherapy.

Sharma N, Saifo M, Tamaskar IR, Bhuvaneswari R, Mashtare T, Fakih M. Sharma N, et al. Among authors: fakih m. J Gastrointest Oncol. 2010 Dec;1(2):90-6. doi: 10.3978/j.issn.2078-6891.2010.022. J Gastrointest Oncol. 2010. PMID: 22811812 Free PMC article.

4

The evolving role of VEGF-targeted therapies in the treatment of metastatic colorectal cancer.

Fakih M. Fakih M. Expert Rev Anticancer Ther. 2013 Apr;13(4):427-38. doi: 10.1586/era.13.20. Epub 2013 Feb 22. Expert Rev Anticancer Ther. 2013. PMID: 23432698 Review.

5

Targeting mechanisms of resistance to anti-EGF receptor therapy in KRAS wild-type colorectal cancer: the path to more personalized medicine.

Fakih M. Fakih M. Future Oncol. 2013 Apr;9(4):551-60. doi: 10.2217/fon.12.204. Future Oncol. 2013. PMID: 23560377 Review.

6

TP53 and let-7a micro-RNA regulate K-Ras activity in HCT116 colorectal cancer cells.

Luu C, Heinrich EL, Duldulao M, Arrington AK, Fakih M, Garcia-Aguilar J, Kim J. Luu C, et al. Among authors: fakih m. PLoS One. 2013 Aug 1;8(8):e70604. doi: 10.1371/journal.pone.0070604. Print 2013. PLoS One. 2013. PMID: 23936455 Free PMC article.

7

Multigene assays in metastatic colorectal cancer.

Deeb KK, Sram JP, Gao H, Fakih MG. Deeb KK, et al. J Natl Compr Canc Netw. 2013 Sep;11 Suppl 4:S9-17. doi: 10.6004/jnccn.2013.0221. J Natl Compr Canc Netw. 2013. PMID: 24158971 Review.

8

The emerging role of neoadjuvant chemotherapy for rectal cancer.

Boland PM, Fakih M. Boland PM, et al. Among authors: fakih m. J Gastrointest Oncol. 2014 Oct;5(5):362-73. doi: 10.3978/j.issn.2078-6891.2014.060. J Gastrointest Oncol. 2014. PMID: 25276409 Free PMC article. Review.

9

Cost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-type RAS metastatic colorectal cancer.

Graham CN, Hechmati G, Fakih MG, Knox HN, Maglinte GA, Hjelmgren J, Barber B, Schwartzberg LS. Graham CN, et al. J Med Econ. 2015;18(8):619-28. doi: 10.3111/13696998.2015.1035659. Epub 2015 May 20. J Med Econ. 2015. PMID: 25822327 Free article.

10

Metastatic colorectal cancer: current state and future directions.

Fakih MG. Fakih MG. J Clin Oncol. 2015 Jun 1;33(16):1809-24. doi: 10.1200/JCO.2014.59.7633. Epub 2015 Apr 27. J Clin Oncol. 2015. PMID: 25918280 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters